The earliest documentation of leukemia was in 1827 by Velpean, but the entity was ignored until 20 years later when cited by Virchow, who was later credited with recognition of "weisses Blut" in 1847. 2 Arsenic oxide was the first substance used to treat leukemia, chronic myeloid leukemia (CML), and produced a complete, although transient, remission. Later, radiotherapy was used. Leukemia was considered virtually incurable until the 1940s.2 Today an arsenal of chemotherapy drugs exists, but current therapies are still not completely effective in treating various leukemias. Approximately 20,500 new cases of leukemia are diagnosed in adults and 2,500 new cases in children each year in the United States. 3 Leukemias are classified into essentially 4 major typesacute myeloid (AML), acute lymphocytic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL), depending on which cell lines are involved. Acute vs. chronic is an historical distinction determined clinically by duration of survival. Paradoxically, with older chemotherapy regimens acute leukemias have been more curable. Acute leukemias are characterized by a maturation arrest resulting in accumulation of immature/undifferentiated, nonfunctional neoplastic cells, or blasts.4 Chemotherapy eliminates the neoplastic clone, allowing reestablishment of normal hematopoiesis. In contrast, chronic leukemias are characterized by accumulation of a spectrum of differentiated cells.4 Apoptosis, or programmed cell death, may also be defective leading to accumulation of mature cells. Therapy is directed at reducing the tumor burden, suppressing the defective clonal element, and returning the patient's life to normal for as long as possible. A better understanding of the different mechanisms causing each type of leukemia will lead to the development of more specific and effective therapy.
